Security key
746964105
Q32 Bio Inc. - Common Stock, par value $0.0001 per share (QTTB)
CUSIP: 746964105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 16,820,491
- Total 13F shares
- 8,065,328
- Share change
- +631,360
- Total reported value
- $144,178,979
- Price per share
- $17.95
- Number of holders
- 54
- Value change
- +$11,388,677
- Number of buys
- 34
- Number of sells
- 10
Report period
Q2 2024
Institutions
54
Top holders
10
QTTB full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Q32 Bio Inc. SEC filings
Q32 Bio Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 746964105
Recent filing periods:
Top shareholders of QTTB - Q32 Bio Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · Director, 10%+ Owner |
13%
|
2,252,987
|
$38,390,898 | — | 31 Mar 2024 | |
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
12%
|
2,092,106
|
$35,649,486 | — | 31 Mar 2024 | |
| Carlyle Group Inc. |
13F
|
Company |
6.6%
|
1,102,741
|
$18,073,925 | — | 31 Mar 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
2.2%
|
370,068
|
$6,305,959 | — | 31 Mar 2024 | |
| ARCH Venture Management, LLC |
13F
|
Company |
1.9%
|
320,482
|
$5,461,013 | — | 31 Mar 2024 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.9%
|
313,943
|
$5,349,589 | — | 31 Mar 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.5%
|
251,994
|
$4,293,978 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
1.1%
|
187,567
|
$3,196,142 | — | 31 Mar 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.65%
|
109,964
|
$1,873,787 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.64%
|
107,752
|
$1,836,094 | — | 31 Mar 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.39%
|
65,021
|
$1,107,958 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.26%
|
44,573
|
$759,524 | — | 31 Mar 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.18%
|
30,000
|
$511,200 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.17%
|
27,777
|
$473,320 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.15%
|
25,731
|
$438,456 | — | 31 Mar 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
0.15%
|
24,894
|
$424,194 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.13%
|
22,335
|
$380,588 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
17,966
|
$306,213 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.09%
|
15,584
|
$265,551 | — | 31 Mar 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
15,133
|
$257,866 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
10,061
|
$171,439 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
9,357
|
$159,444 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
3,695
|
$62,000 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.02%
|
3,513
|
$59,862 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
2,983
|
$50,830 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
940
|
$16,017 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
723
|
$12,320 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
79
|
$1,346 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
65
|
$1,107 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
55
|
$1,000 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
51
|
$869 | — | 31 Mar 2024 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
45
|
$767 | — | 31 Mar 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
39
|
$665 | — | 31 Mar 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
25
|
$426 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
15
|
$255 | — | 31 Mar 2024 | |
| BFSG, LLC |
13F
|
Company |
0%
|
11
|
$188 | — | 31 Mar 2024 | |
| ST GERMAIN D J CO INC |
13F
|
Company |
0%
|
11
|
$187 | — | 31 Mar 2024 | |
| THOMPSON INVESTMENT MANAGEMENT, INC. |
13F
|
Company |
0%
|
4
|
$68 | — | 31 Mar 2024 | |
| Atlas Venture Fund X, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,092,106
|
$1,194,801 | — | 25 Mar 2024 | |
| W. Bradford Smith |
3/4/5
|
Chief Financial and Business Officer and Treasurer |
—
mixed-class rows
|
249,000
mixed-class rows
|
$2,899,867 | — | 23 Feb 2023 | |
| Michael L. Blum |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
121,000
mixed-class rows
|
$1,415,233 | — | 23 Feb 2023 | |
| Timothy P. Kelly |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
33,000
mixed-class rows
|
$383,965 | — | 24 Feb 2022 | |
| Alise Reicin |
3/4/5
|
Director |
—
class O/S missing
|
23,000
|
$308,660 | — | 14 Jun 2023 | |
| Jeffrey V Poulton |
3/4/5
|
Director |
—
class O/S missing
|
23,000
|
$308,660 | — | 14 Jun 2023 | |
| Matthew R. Patterson |
3/4/5
|
Director |
—
class O/S missing
|
23,000
|
$308,660 | — | 14 Jun 2023 | |
| Steven Gillis |
3/4/5
|
Director |
—
class O/S missing
|
23,000
|
$308,660 | — | 14 Jun 2023 | |
| Kush Parmar |
3/4/5
|
Director |
—
class O/S missing
|
18,000
|
$241,560 | — | 15 Jun 2022 | |
| Richard J. Gregory |
3/4/5
|
Director |
—
class O/S missing
|
18,000
|
$241,560 | — | 15 Jun 2022 | |
| Albert Seymour |
3/4/5
|
President and Chief Executive Officer, Director |
—
mixed-class rows
|
160,254
mixed-class rows
|
$96,184 | — | 06 Sep 2023 | |
| Gabriel Cohn |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
11,339
mixed-class rows
|
$11,506 | — | 01 Jan 2022 |
Institutional Holders of Q32 Bio Inc. - Common Stock, par value $0.0001 per share (QTTB) as of Q2 2024
As of 30 Jun 2024,
Q32 Bio Inc. - Common Stock, par value $0.0001 per share (QTTB) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,065,328 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Atlas Venture Life Science Advisors, LLC, Carlyle Group Inc., BlackRock Inc., ARCH Venture Management, LLC, Temasek Holdings (Private) Ltd, 5AM Venture Management, LLC, FMR LLC, HARVARD MANAGEMENT CO INC, and ADAR1 Capital Management, LLC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
38
Q2 2024 holders
54
Holder diff
16
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.